| Robust Annual Growth in the Renal Cell Carcinoma Drug Market Will be Driven by ... - PR-CANADA.net (press release) |
|
|
PR-CANADA.net (press release)The Pharmacor 2010 findings from the topic entitled Renal Cell Carcinoma reveal that significant uptake of the angiogenesis inhibitor Votrient/Patorma will ... read more |